Age-Related Macular Degeneration (Amd) Market Report

Age-Related Macular Degeneration (Amd) Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Oct 19, 2019
  • PAGES：180
  • REPORT CODE：GMM333325
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Age-Related Macular Degeneration (Amd) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 12.4% during the forecast period.

    This report presents the market size and development trends by detailing the Age-Related Macular Degeneration (Amd) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Age-Related Macular Degeneration (Amd) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Age-Related Macular Degeneration (Amd) industry and will help you to build a panoramic view of the industrial development.

    Age-Related Macular Degeneration (Amd) Market, By Type:

    • Type 1

    • Type 2

    • Type 3

    Age-Related Macular Degeneration (Amd) Market, By Application:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    Some of the leading players are as follows:

    • F Hoffmann-La Roche Ltd.

    • F. Hoffmann-La Roche Ltd

    • Stemcells Inc.

    • Bayer Ag

    • Alimera Sciences, Inc

    • Regeneron Pharmaceutical, Inc.

    • Ophthotech Corporation

    • Acucela

    • Novartis Ag.

    • Glaxosmithkline Plc.

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Age-Related Macular Degeneration (Amd) Market: Technology Type Analysis

    • 4.1 Age-Related Macular Degeneration (Amd) Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Age-Related Macular Degeneration (Amd) Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Type 1

      • 4.3.2 Type 2

      • 4.3.3 Type 3

    5 Age-Related Macular Degeneration (Amd) Market: Product Analysis

    • 5.1 Age-Related Macular Degeneration (Amd) Product Market Share Analysis, 2018 & 2026

    • 5.2 Age-Related Macular Degeneration (Amd) Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Age-Related Macular Degeneration (Amd) Market: Application Analysis

    • 6.1 Age-Related Macular Degeneration (Amd) Application Market Share Analysis, 2018 & 2026

    • 6.2 Age-Related Macular Degeneration (Amd) Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 End-User 1

      • 6.3.2 End-User 1

      • 6.3.3 End-User 3

    7 Age-Related Macular Degeneration (Amd) Market: Regional Analysis

    • 7.1 Age-Related Macular Degeneration (Amd) Regional Market Share Analysis, 2018 & 2026

    • 7.2 Age-Related Macular Degeneration (Amd) Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 F Hoffmann-La Roche Ltd.

      • 9.1.1 F Hoffmann-La Roche Ltd. Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 F. Hoffmann-La Roche Ltd

      • 9.2.1 F. Hoffmann-La Roche Ltd Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Stemcells Inc.

      • 9.3.1 Stemcells Inc. Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Bayer Ag

      • 9.4.1 Bayer Ag Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Alimera Sciences, Inc

      • 9.5.1 Alimera Sciences, Inc Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Regeneron Pharmaceutical, Inc.

      • 9.6.1 Regeneron Pharmaceutical, Inc. Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Ophthotech Corporation

      • 9.7.1 Ophthotech Corporation Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Acucela

      • 9.8.1 Acucela Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Novartis Ag.

      • 9.9.1 Novartis Ag. Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Glaxosmithkline Plc.

      • 9.10.1 Glaxosmithkline Plc. Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

     

    The List of Tables and Figures (Totals 65 Figures and 156 Tables)

    • Figure Type 1 Age-Related Macular Degeneration (Amd) market, 2015 - 2026 (USD Million)

    • Figure Type 2 Age-Related Macular Degeneration (Amd) market, 2015 - 2026 (USD Million)

    • Figure Type 3 Age-Related Macular Degeneration (Amd) market, 2015 - 2026 (USD Million)

    • Figure End-Users 1 market, 2015 - 2026 (USD Million)

    • Figure End-Users 2 market, 2015 - 2026 (USD Million)

    • Figure End-Users 3 market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Age-Related Macular Degeneration (Amd) market, by country, 2015 - 2026 (USD Million)

    • Table North America Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table North America Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table North America Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Canada Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Canada Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Europe Age-Related Macular Degeneration (Amd) market, by country, 2015 - 2026 (USD Million)

    • Table Europe Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Europe Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Europe Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Germany Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Germany Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table France Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table France Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Italy Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Italy Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Spain Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Spain Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table China Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table China Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Japan Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Japan Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table India Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table India Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Age-Related Macular Degeneration (Amd) market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table MEA Age-Related Macular Degeneration (Amd) market, by country, 2015 - 2026 (USD Million)

    • Table MEA Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table MEA Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table MEA Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Age-Related Macular Degeneration (Amd) market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Age-Related Macular Degeneration (Amd) market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Age-Related Macular Degeneration (Amd) market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table F Hoffmann-La Roche Ltd. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table F. Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Stemcells Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer Ag Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alimera Sciences, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Regeneron Pharmaceutical, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ophthotech Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Acucela Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Ag. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Glaxosmithkline Plc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US